Approvals/CIMA-AEMPS/SEVIKAR HCT 40 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

SEVIKAR HCT 40 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA

Daiichi Sankyo Belgium🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: a0c2c18b372a9fac
Drug Cima Aemps Name: SEVIKAR HCT 40 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: BE387475
Holder Company Name: Daiichi Sankyo Belgium
Marketing Company Name: Elam Pharma Labs S.L.
Authorization Date: 2021-11-11
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 40 mg/5mg/12,5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Daiichi Sankyo Belgium

OLMESARTAN MEDOXOMILO

40,000 mg

AMLODIPINO BESILATO

6,944 mg

HIDROCLOROTIAZIDA

12,500 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Nov 11, 2021

Approval ID

a0c2c18b372a9fac

Type

Standard